Caribou Biosciences Inc (NASDAQ: CRBU) — Healthcare · Share Price, Chart & Market Data
About: Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $2.17 (+1.88%)
CRBUCaribou Biosciences Inc
Loading watchlist status…
Trade CRBU now
Caribou Biosciences Inc share price
CRBU price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 4:30 pm GMT+0
CRBU price performance
-3.556%
5D
21.91%
1M
36.478%
YTD
181.197%
1Y
CRBU price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 4:30 pm GMT+0
CRBU details
CRBU Market Signals